CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock |
Beginning balance (in shares) at Jan. 29, 2023 | | | 132,453,000 | | | | |
Beginning balance at Jan. 29, 2023 | | $ 1,701,051 | $ 1,325 | $ 572,455 | $ 1,141,819 | $ (13,809) | $ (739) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 156,531 | | | 156,531 | | |
Foreign currency translation adjustments | | (2,205) | | | | (2,205) | |
Change in fair value of derivative financial instruments, net of tax | | 242 | | | | 242 | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (486) | | | | (486) | |
Conversion/release of stock-based awards (in shares) | [1] | | 996,000 | | | | |
Conversion/release of stock-based awards | [1] | (49,518) | $ 10 | (49,327) | | | (201) |
Repurchase of common stock (in shares) | [2] | | (5,005,000) | | | | |
Repurchases of common stock 2 | [2] | (302,401) | $ (50) | (14,778) | (286,573) | | (1,000) |
Reissuance of treasury stock under stock-based compensation plans | [1] | 0 | | (334) | (180) | | 514 |
Stock-based compensation expense | | 23,282 | | 23,282 | | | |
Dividends declared | | (59,671) | | | (59,671) | | |
Ending balance (in shares) at Apr. 30, 2023 | | | 128,444,000 | | | | |
Ending balance at Apr. 30, 2023 | | 1,466,825 | $ 1,285 | 531,298 | 951,926 | (16,258) | (1,426) |
Beginning balance (in shares) at Jan. 29, 2023 | | | 132,453,000 | | | | |
Beginning balance at Jan. 29, 2023 | | 1,701,051 | $ 1,325 | 572,455 | 1,141,819 | (13,809) | (739) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 358,038 | | | | | |
Foreign currency translation adjustments | | (34) | | | | | |
Change in fair value of derivative financial instruments, net of tax | | 85 | | | | | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (782) | | | | | |
Ending balance (in shares) at Jul. 30, 2023 | | | 128,289,000 | | | | |
Ending balance at Jul. 30, 2023 | | 1,620,955 | $ 1,283 | 550,866 | 1,084,772 | (14,540) | (1,426) |
Beginning balance (in shares) at Apr. 30, 2023 | | | 128,444,000 | | | | |
Beginning balance at Apr. 30, 2023 | | 1,466,825 | $ 1,285 | 531,298 | 951,926 | (16,258) | (1,426) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 201,507 | | | 201,507 | | |
Foreign currency translation adjustments | | 2,171 | | | | 2,171 | |
Change in fair value of derivative financial instruments, net of tax | | (157) | | | | (157) | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | (296) | | | | (296) | |
Conversion/release of stock-based awards (in shares) | [1] | | 25,000 | | | | |
Conversion/release of stock-based awards | [1] | (432) | | (432) | | | |
Repurchase of common stock (in shares) | [2] | | (180,000) | | | | |
Repurchases of common stock 2 | [2] | (10,096) | $ (2) | (547) | (9,547) | | |
Stock-based compensation expense | | 20,547 | | 20,547 | | | |
Dividends declared | | (59,114) | | | (59,114) | | |
Ending balance (in shares) at Jul. 30, 2023 | | | 128,289,000 | | | | |
Ending balance at Jul. 30, 2023 | | 1,620,955 | $ 1,283 | 550,866 | 1,084,772 | (14,540) | (1,426) |
Beginning balance (in shares) at Jan. 28, 2024 | | | 128,301,000 | | | | |
Beginning balance at Jan. 28, 2024 | | 2,127,861 | $ 1,284 | 587,960 | 1,555,595 | (15,552) | (1,426) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 265,666 | | | 265,666 | | |
Foreign currency translation adjustments | | (1,342) | | | | (1,342) | |
Change in fair value of derivative financial instruments, net of tax | | 1 | | | | 1 | |
Conversion/release of stock-based awards (in shares) | [3] | | 687,000 | | | | |
Conversion/release of stock-based awards | [3] | (87,008) | $ 6 | (86,787) | | | (227) |
Repurchase of common stock (in shares) | | | (313,000) | | | | |
Repurchases of common stock 2 | | (43,781) | $ (2) | (957) | (42,822) | | |
Reissuance of treasury stock under stock-based compensation plans | [3] | 0 | | (1,218) | | | 1,218 |
Stock-based compensation expense | | 22,191 | | 22,191 | | | |
Dividends declared | | (74,030) | | | (74,030) | | |
Ending balance (in shares) at Apr. 28, 2024 | | | 128,675,000 | | | | |
Ending balance at Apr. 28, 2024 | | 2,209,558 | $ 1,288 | 521,189 | 1,704,409 | (16,893) | (435) |
Beginning balance (in shares) at Jan. 28, 2024 | | | 128,301,000 | | | | |
Beginning balance at Jan. 28, 2024 | | 2,127,861 | $ 1,284 | 587,960 | 1,555,595 | (15,552) | (1,426) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 491,411 | | | | | |
Foreign currency translation adjustments | | (1,391) | | | | | |
Change in fair value of derivative financial instruments, net of tax | | 1 | | | | | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | 94 | | | | | |
Ending balance (in shares) at Jul. 28, 2024 | | | 127,788,000 | | | | |
Ending balance at Jul. 28, 2024 | | 2,250,230 | $ 1,278 | 538,172 | 1,728,063 | (16,848) | (435) |
Beginning balance (in shares) at Apr. 28, 2024 | | | 128,675,000 | | | | |
Beginning balance at Apr. 28, 2024 | | 2,209,558 | $ 1,288 | 521,189 | 1,704,409 | (16,893) | (435) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | |
Net earnings | | 225,745 | | | 225,745 | | |
Foreign currency translation adjustments | | (49) | | | | (49) | |
Change in fair value of derivative financial instruments, net of tax | | 0 | | | | | |
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax | | 94 | | | | 94 | |
Conversion/release of stock-based awards (in shares) | [3] | | 35,000 | | | | |
Conversion/release of stock-based awards | [3] | (1,842) | | (1,842) | | | |
Repurchase of common stock (in shares) | [2] | | (922,000) | | | | |
Repurchases of common stock 2 | [2] | (130,518) | $ (10) | (2,808) | (127,700) | | |
Stock-based compensation expense | | 21,633 | | 21,633 | | | |
Dividends declared | | (74,391) | | | (74,391) | | |
Ending balance (in shares) at Jul. 28, 2024 | | | 127,788,000 | | | | |
Ending balance at Jul. 28, 2024 | | $ 2,250,230 | $ 1,278 | $ 538,172 | $ 1,728,063 | $ (16,848) | $ (435) |
| |
[1]Amounts are shown net of shares withheld for employee taxes[2] Repurchases of common stock include accrued excise taxes of $2.5 million as of July 30, 2023, which is recorded in retained earnings. Amounts are shown net of shares withheld for employee taxes. 2 Repurchases of common stock include accrued excise taxes of $0.7 million as of July 28, 2024, which is recorded in retained earnings. | |